Allarity Therapeutics, Inc. Capital Expenditures
Allarity Therapeutics, Inc. (ALLR) reported Capital Expenditures of $64.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-08-14
- Allarity Therapeutics, Inc. payments to acquire property, plant, and equipment for the quarter ending 2026-06-30 was $0.00.
- Allarity Therapeutics, Inc. payments to acquire property, plant, and equipment for the quarter ending 2026-03-31 was $64.00K.
- Allarity Therapeutics, Inc. payments to acquire property, plant, and equipment for the quarter ending 2025-06-30 was $0.00.
- Allarity Therapeutics, Inc. payments to acquire property, plant, and equipment for the quarter ending 2025-03-31 was $0.00.
- Allarity Therapeutics, Inc. payments to acquire property, plant, and equipment for fiscal 2025 was $8.00K, a 97.32% decline from fiscal 2024.
- Allarity Therapeutics, Inc. payments to acquire property, plant, and equipment for fiscal 2024 was $298.00K.
- Allarity Therapeutics, Inc. payments to acquire property, plant, and equipment for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- Allarity Therapeutics, Inc. payments to acquire property, plant, and equipment for fiscal 2022 was $18.00K.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $64.00K 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $64.00K 10-Q · filed 2026-05-15 | ||
| 2025-12-31 | $8.00K 10-K · filed 2026-03-30 | ||
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $0.00 10-Q · filed 2026-08-14 | |
| 2025-03-31 | $0.00 10-Q · filed 2026-05-15 | ||
| 2024-12-31 | $298.00K 10-K · filed 2026-03-30 | ||
| 2023-12-31 | $0.00 10-K · filed 2025-03-31 | ||
| 2022-12-31 | $18.00K 10-K · filed 2024-03-08 | ||
| 2020-12-31 | $3.00K 10-K · filed 2022-05-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B |